Molnlycke Health Care Group AB engages in the manufacture and supply of single-use surgical and wound care products and services to the professional health care sector worldwide. It operates through two divisions, Surgical and Wound Care. The Surgical division offers various products, such as drapes, packs and staff clothing, procedure trays, surgical powder free gloves, and skin antiseptics, as well as various service solutions. This division offers its products under the brands BARRIER, Biogel, HibiAntiseptics, and ProcedurePak. The Wound Care division offers wound healing and various products based on patented soft silicone technology, as well as surgical, absorbent, and fixation dressings. It also offers supplementary portfolios in compression, dermatology, and orthopedics, as well as Xelma, an extracellular matrix protein for hard-to-heal wounds. The company’s services include conversions expertise, which analyze various costs and benefits that are involved; customer service center; eConnect, which is an electronic interface for exchange of information in the order to payment process; education support; Molnlycke Health Care Surgical Forum, which offers service and platform for interaction with and between its customers; and Molnlycke Health Care Wound Care Forum, which produce a library of educational materials and best practice documents. It also offers operating room expertise; price per procedure, which provides cost control tool and simplify the administrative work; and SupplyPartner, which supplies goods in right time and quantity. Molnlycke Health Care Group was founded in 1997 and is headquartered in Goteborg, Sweden.